Table 2.
Molecular target | Mechanism | Effect | References |
---|---|---|---|
VGCCs | inhibition of calcium influx into the neuron and decreases its excitability | anti-seizures | [115] |
presynaptic proteins engaged in the organization of glutamatergic synapses | interference with the formation and maturation of glutamatergic synapses | anti-epileptogenic? | [118] |
neurexin-1α, and adhesion molecules (thrombospondins) | inhibition of aberrant excitatory synaptogenesis |
analgesia, detrimental effect in the absence epilepsy |
[8, 120, 122] |
AMPAR | controlling the subunit composition and Ca2+ permeability of postsynaptic AMPARs | analgesia | [121] |
NMDAR | interference with the phosphorylation of NMDAR, in this way, affecting neuroplasticity | anti-epileptogenic? | [122] |
PI3K/Akt/mTOR pathway | preventing the oxidative stress-related autophagy via the activation of the PI3K/Akt/mTOR pathway |
neuroprotective, anti-epileptogenic? |
[123] |
VGCCs - voltage-gated Ca2 + channels, AMPAR - α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor, NMDAR– N-methyl-D-aspartate receptor, PI3K/Akt/mTOR - the phosphoinositide 3 kinase (PI3K)/Akt/mammalian (or mechanistic) target of the rapamycin (mTOR) pathway